文献速递神经胸部CT

基于脑CT影像组学特征区分伴脑转移的原发性肺癌病理亚型

Differentiating the pathological subtypes of primary lung cancer for patients with brain metastases based on radiomics features from brain CT images.
PubMed 文献 · Eur Radiol · 2020-08-21

本研究纳入144例脑转移患者(原发肺腺癌102例、鳞癌42例),从脑增强CT手动勾画肿瘤中提取105个影像组学特征,经Mann-Whitney U检验与LASSO logistic回归筛选出14个特征,用二分类logistic回归和支持向量机建模。仅影像组学模型AUC为0.765 vs. 0.769、准确率0.795 vs. 0.828;影像组学联合年龄和性别模型AUC为0.716 vs. 0.726、准确率0.768 vs. 0.758。作者认为脑增强CT影像组学在区分腺癌与鳞癌方面有前景。

要点

  • 脑增强CT影像组学最高AUC为0.828、准确率0.758,用于区分肺腺癌与鳞癌脑转移。
  • 共筛选14个影像组学特征用于建模,样本为144例脑转移患者(腺癌102例、鳞癌42例)。
  • 脑增强CT与MRI在检出脑转移方面被推荐处于同等地位,常为筛查转移的初始影像方法。

核心结论

  • 脑增强CT影像组学在区分非小细胞肺癌脑转移患者原发腺癌与鳞癌方面有前景,有助于实现最佳治疗管理。

研究设计与样本

  • 本研究共纳入144例脑转移患者,其中男性94例、女性50例,原发肺腺癌102例、鳞癌42例。
  • 从手动勾画的肿瘤中提取影像组学特征,采用Mann-Whitney U检验与LASSO logistic回归筛选特征。
  • 采用二分类logistic回归和支持向量机分别构建仅影像组学特征模型及影像组学特征联合年龄和性别模型。

诊断标准与关键数值

  • 从105个影像组学特征中筛选出14个特征用于最终建模。
  • 仅影像组学特征模型:支持向量机AUC 0.765、准确率0.795,二分类logistic回归AUC 0.769、准确率0.828。
  • 影像组学特征联合年龄和性别模型:支持向量机AUC 0.716、准确率0.768,二分类logistic回归AUC 0.726、准确率0.758。

临床应用与阅片要点

  • 脑增强CT常为筛查脑转移的初始影像方法,并被推荐与MRI在检出脑转移方面处于同等地位。
  • 对伴脑转移的非小细胞肺癌患者,可基于脑增强CT影像组学区分原发腺癌与鳞癌,以辅助治疗管理。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: It is of high clinical importance to identify the primary lesion and its pathological types for patients with brain metastases (BM). The purpose of this study is to investigate the feasibility and accuracy of differentiating the primary adenocarcinoma (AD) and squamous cell carcinoma (SCC) of non-small-cell lung cancer (NSCLC) for patients with BM based on radiomics from brain contrast-enhanced computer tomography (CECT) images.

METHODS: A total of 144 BM patients (94 male, 50 female) were enrolled in this study with 102 with primary lung AD and 42 with SCC, respectively. Radiomics features from manually contoured tumors were extracted using python. Mann-Whitney U test and the least absolute shrinkage and selection operator (LASSO) logistic regression were applied to select relative radiomics features. Binary logistic regression and support vector machines (SVM) were applied to build models with radiomics features alone and with radiomics features plus age and sex.

RESULTS: Fourteen features were selected from a total of 105 radiomics features for the final model building. The area under the curves (AUCs) and accuracy of SVM and binary logistic regression models were 0.765 vs. 0.769, 0.795 vs.0.828, and 0.716 vs. 0.726, 0.768 vs. 0.758, respectively, for models with radiomics features alone and models with radiomics features plus sex and age.

CONCLUSIONS: Brain CECT radiomics are promising in differentiating primary AD and SCC to achieve optimal therapeutic management in patients with BM from NSCLC.

KEY POINTS: • It is of high clinical importance to identify the primary lesion and its pathological types for patients with brain metastases (BM) to define the prognosis and treatment. • Few studies had investigated the feasibility and accuracy of differentiating the pathological subtypes of primary non-small-cell lung cancer between adenocarcinoma (AD) and squamous cell carcinoma (SCC) for patients with BM based on radiomics from brain contrast-enhanced CT (CECT) images, although CECT images are often the initial imaging modality to screen for metastases and are recommended on equal footing with MRI for the detection of cerebral metastases. • Brain CECT radiomics are promising in differentiating primary AD and SCC to achieve optimal therapeutic management in patients with BM from NSCLC with a highest area under the curve (AUC) of 0.828 and an accuracy of 0.758, respectively.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Zhang J, Jin J, Ai Y, et al. Differentiating the pathological subtypes of primary lung cancer for patients with brain metastases based on radiomics features from brain CT images. Eur Radiol. 2020. PMID: 32822055. doi:10.1007/s00330-020-07183-z

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。